Legal Representation
Attorney
Jong H Park
USPTO Deadlines
Next Deadline
599 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210928)
Due Date
September 28, 2027
Grace Period Ends
March 28, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 28, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 26, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Aug 25, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Aug 19, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 19, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 19, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 5, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jul 21, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Aug 2, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 21, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 3, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 1, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 1, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 1, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 1, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 7, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 7, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 17, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 4, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 4, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 4, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 4, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 3, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 26, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 21, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 21, 2020 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| May 21, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 21, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 4, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 4, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 4, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 25, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 10, 2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 9, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 29, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
product development, namely, development of cell therapy products; research services in the field of cell separation; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; genetic testing, namely, biological information check, for medical research use; product development, namely, biologics development; research in the field of biologics; biological analysis; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes
First Use Anywhere:
Sep 17, 2019
First Use in Commerce:
Mar 17, 2020
Class 044
immunotherapy services related to the treatment of cancers; medical services relating to the removal, treatment and processing of human cells for the purpose of stem cell therapy; analysis of human tissues for medical treatment purposes; providing a database featuring information regarding immune cells for medical purposes; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow for medical treatment purposes; medical and health services relating to DNA screening for medical purposes; genetic testing for medical purposes; provision of gene therapy for medical purposes; medical analysis services for the diagnosis and prognosis of cancer; medical analysis services for the diagnosis and prognosis of cancer, namely, RNA or DNA analysis for cancer diagnosis and prognosis; providing information in the field of cancer prevention, screening, diagnosis and treatment; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
First Use Anywhere:
Sep 17, 2019
First Use in Commerce:
Mar 17, 2020
Additional Information
Design Mark
The mark consists of the word "TAST" surrounded by an oblong, with a four point star in the center of the letter "A".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
042
044